Acorda Therapeutics Total Non Current Liabilities 2011-2026 | ACOR

Annual Total Non Current Liabilities Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	257 M	403 M	547 M	534 M	530 M	423 M	426 M	70.1 M	80.5 M	86.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
547 M	70.1 M	336 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	165 M	$ 2.08	-14.4 %	$ 214 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Altimmune ALT	5.33 M	$ 4.2	-2.67 %	$ 298 M	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.24	-3.44 %	$ 2.55 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.8	1.87 %	$ 4.36 M	China
Aprea Therapeutics APRE	303 K	$ 0.88	-3.72 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	5 M	$ 7.2	-1.64 %	$ 1.99 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Aquestive Therapeutics AQST	90.3 M	$ 4.1	2.37 %	$ 356 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 8.35	1.46 %	$ 225 M	Israel
Ardelyx ARDX	50.9 M	$ 6.37	-2.75 %	$ 1.54 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
argenx SE ARGX	226 M	$ 756.71	-1.33 %	$ 25 B	Niderland
Armata Pharmaceuticals ARMP	14 M	$ 10.91	1.58 %	$ 394 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 25.33	-6.1 %	$ 3.22 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Arvinas ARVN	42.1 M	$ 12.97	-2.3 %	$ 920 M	USA
Arrowhead Pharmaceuticals ARWR	686 M	$ 61.74	-2.42 %	$ 8.26 B	USA
Ascendis Pharma A/S ASND	101 M	$ 231.56	-0.83 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.39	-1.63 %	$ 8.16 B	Australia
Actinium Pharmaceuticals ATNM	682 K	$ 1.17	-0.85 %	$ 35.2 M	USA
Atossa Therapeutics ATOS	11.1 K	$ 4.39	-0.9 %	$ 553 M	USA
Atara Biotherapeutics ATRA	15.4 M	$ 5.01	-7.47 %	$ 37.5 M	USA
Aurinia Pharmaceuticals AUPH	41.9 M	$ 14.14	-0.21 %	$ 1.9 B	Canada
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.68	-1.75 %	$ 429 M	Britain
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Atea Pharmaceuticals AVIR	69.2 M	$ 4.69	0.21 %	$ 395 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Anavex Life Sciences Corp. AVXL	332	$ 4.54	2.44 %	$ 387 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Axon Enterprise AXON	107 M	$ 570.5	5.18 %	$ 43.2 B	USA
Axsome Therapeutics AXSM	48.9 M	$ 162.28	-0.98 %	$ 8.07 B	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Aytu BioScience AYTU	42.1 M	$ 2.56	-0.58 %	$ 16.1 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA